Randomized, Placebo-Controlled, Phase II Study of Sequential Erlotinib and Chemotherapy As First-Line Treatment for Advanced Non-Small-Cell Lung Cancer

Author

MOK, Tony S. K; WU, Yi-Long; CHUA-TAN, Marina; SRIURANPONG, Virote; SUDOYO, Aru W; JIN, Kate; JOHNSTON, Michael; CHUI, Winsome; LEE, Jin-Soo; YU, Chong-Jen; CAICUN ZHOU; CHEN, Yuh-Min; LI ZHANG; IGNACIO, Jorge; MEILIN LIAO; SRIMUNINNIMIT, Vichien; BOYER, Michael
[1] The Chinese University of Hong Kong, Sir YK Pau Cancer Center, State Key Laboratory of Southern China, Prince of Wales Hospital, China
[2] Roche Hong Kong, Hong-Kong
[3] Guangdong General Hospital; Cancer Center of Sun Yat-Sen University, Guangzhou, China
[4] Shanghai Pulmonary Hospital, China
[5] Shanghai Chest Hospital, Shanghai, China
[6] National Taiwan University Hospital, Taiwan, Province of China
[7] Taipei Veterans General Hospital, School of Medicine, National Yang-Ming University, Taipei, Taiwan, Province of China
[8] Philippine General Hospital; Cardinal Santos Medical Center, Manila, Philippines
[9] Faculty of Medicine, Siriraj Hospital, Mahidol University, Thailand
[10] The King Chulalongkorn Memorial Hospital and Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
[11] Sydney Cancer Centre, Australia
[12] Roche Products, Sydney, Australia
[13] Cipto Mangunkusumo General Hospital, Jakarta, Indonesia
[14] National Cancer Center, Goyang, Gyeonggi, Korea, Republic of

Source

Journal of clinical oncology. 2009, Vol 27, Num 30, pp 5080-5087, 8 p ; ref : 29 ref

ISSN

0732-183X

Scientific domain

Medical oncology

Publisher

American Society of Clinical Oncology, Alexandria, VA

Publication country

United States

Document type

Article

Language

English

Keyword (fr)

Anticancéreux Cancer du poumon Cancérologie Carcinome non petite cellule bronchopulmonaire Erlotinib Essai clinique phase II Placebo Randomisation Stade avancé Séquentiel Traitement de première intention Cancer Dérivé de la quinazoline Enzyme Inhibiteur de la tyrosine kinase Inhibiteur enzyme Pathologie de l'appareil respiratoire Pathologie des bronches Pathologie des poumons Protein-tyrosine kinase Transferases Tumeur maligne

Keyword (en)

Antineoplastic agent Lung cancer Cancerology non-small cell lung carcinoma Erlotinib Phase II trial Placebo Randomization Advanced stage Sequential First line treatment Cancer Quinazoline derivatives Enzyme Tyrosine kinase inhibitor Enzyme inhibitor Respiratory disease Bronchus disease Lung disease Protein-tyrosine kinase Transferases Malignant tumor

Keyword (es)

Anticanceroso Cáncer del pulmón Cancerología Carcinoma no pequeňa célula bronchopulmonar Erlotinib Ensayo clínico fase II Placebo Aleatorización Estadio avanzado Secuencial Tratamiento de primera línea Cáncer Enzima Inhibidor tyrosine kinase Inhibidor enzima Aparato respiratorio patología Bronquio patología Pulmón patología Protein-tyrosine kinase Transferases Tumor maligno

Classification

Pascal

002 Biological and medical sciences / 002B Medical sciences / 002B04 Tumors

Pascal

002 Biological and medical sciences / 002B Medical sciences / 002B11 Pneumology / 002B11A Tumors of the respiratory system and mediastinum

Discipline

Pulmonology Tumours

Origin

Inist-CNRS

Database

PASCAL

INIST identifier

22044339

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS